Ado-trastuzumab emtansine Intravenous and Insulin glargine and lixisenatide
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Ado-trastuzumab emtansine Intravenous-Insulin glargine, recombinant Subcutaneous
- Ado-trastuzumab emtansine Intravenous-Insulin glulisine
- Ado-trastuzumab emtansine Intravenous-Insulin Glulisine (Cartridges and Pens)
- Ado-trastuzumab emtansine Intravenous-Insulin Glulisine (Vials)
- Ado-trastuzumab emtansine Intravenous-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Adox Pak 2/100
- Insulin glargine and lixisenatide-Adoxa
- Insulin glargine and lixisenatide-Adoxa CK
- Insulin glargine and lixisenatide-Adoxa Pak
- Insulin glargine and lixisenatide-Adoxa Pak 1/100
- Insulin glargine and lixisenatide-Adoxa Pak 1/150